Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:10 AM
Ignite Modification Date:
2025-12-25 @ 4:10 AM
NCT ID:
NCT02150720
Eligibility Criteria:
Inclusion Criteria:
* Patients over 18 years
* Patients with unilateral subcapital femoral fracture
* Patients requiring hip replacement (total or partial)
* Signed informed consent from the patient or legal representative
Exclusion Criteria:
* Known allergy to fibrin glue and tranexamic acid
* Multiple fractures
* Pathological fractures
* Contraceptives or estrogen therapy
* Use of blood salvage during surgery
* History compatible with thromboembolic disease:
* Cerebral vascular accident
* Ischemic heart disease (myocardial infarction, angina )
* Deep vein thrombosis
* Pulmonary Embolism
* Peripheral arterial vasculopathy
* Patients with thrombogenic arrhythmias
* Patients with cardiovascular stents
* Prothrombotic alterations in coagulation
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT02150720
Study Brief:
Protocol Section:
NCT02150720